205 related articles for article (PubMed ID: 12057699)
1. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
Jackson CH; Sharples LD; McNeil K; Stewart S; Wallwork J
J Heart Lung Transplant; 2002 Jun; 21(6):658-66. PubMed ID: 12057699
[TBL] [Abstract][Full Text] [Related]
2. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
[TBL] [Abstract][Full Text] [Related]
3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
Lama VN; Murray S; Mumford JA; Flaherty KR; Chang A; Toews GB; Peters-Golden M; Martinez FJ
Am J Respir Crit Care Med; 2005 Aug; 172(3):379-83. PubMed ID: 15894603
[TBL] [Abstract][Full Text] [Related]
8. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival.
Brugière O; Pessione F; Thabut G; Mal H; Jebrak G; Lesèche G; Fournier M
Chest; 2002 Jun; 121(6):1883-9. PubMed ID: 12065353
[TBL] [Abstract][Full Text] [Related]
10. Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical Trial of Inhaled Liposomal Cyclosporine Plus Standard-of-Care Versus Standard-of-Care Alone for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Iacono A; Wijesinha M; Völp A; Korotun M; Terrin M
Ann Transplant; 2024 May; 29():e942823. PubMed ID: 38741362
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
12. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
Verleden GM; Dupont LJ; Van Raemdonck D; Vanhaecke J
J Heart Lung Transplant; 2003 Aug; 22(8):908-13. PubMed ID: 12909472
[TBL] [Abstract][Full Text] [Related]
13. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
Fisher AJ; Wardle J; Dark JH; Corris PA
J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
[TBL] [Abstract][Full Text] [Related]
14. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
15. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
16. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
Ikonen T; Harjula AL; Kinnula VL; Savola J; Sovijärvi A
J Heart Lung Transplant; 1995; 14(2):244-50. PubMed ID: 7779842
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.
Nathan SD; Shlobin OA; Reese E; Ahmad S; Fregoso M; Athale C; Barnett SD
Respir Med; 2009 Dec; 103(12):1816-21. PubMed ID: 19682883
[TBL] [Abstract][Full Text] [Related]
18. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
19. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
[TBL] [Abstract][Full Text] [Related]
20. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
